These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
346 related items for PubMed ID: 18754014
41. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Chorne N, Leonard C, Piecuch R, Clyman RI. Pediatrics; 2007 Jun; 119(6):1165-74. PubMed ID: 17545385 [Abstract] [Full Text] [Related]
42. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwaesei C, Vincer M, TIPP Investigators. J Pediatr; 2006 Jun; 148(6):730-734. PubMed ID: 16769377 [Abstract] [Full Text] [Related]
43. Early enteral feeding does not affect the incidence of necrotizing enterocolitis. Ostertag SG, LaGamma EF, Reisen CE, Ferrentino FL. Pediatrics; 1986 Mar; 77(3):275-80. PubMed ID: 3081868 [Abstract] [Full Text] [Related]
44. [Patent ductus arteriosus. A common clinical problem in extremely premature infants]. Edstedt-Bonamy AK, Johansson S, Milerad J. Lakartidningen; 2000 Dec 06; 97(49):5756-61. PubMed ID: 11188032 [Abstract] [Full Text] [Related]
45. Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus. Lilien LD, Srinivasan G, Yeh TF, Pildes RS. Pediatr Pharmacol (New York); 1985 Dec 06; 5(1):73-7. PubMed ID: 3887313 [Abstract] [Full Text] [Related]
48. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Cherif A, Jabnoun S, Khrouf N. Am J Perinatol; 2007 Jun 06; 24(6):339-45. PubMed ID: 17564958 [Abstract] [Full Text] [Related]
50. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. Bell EF, Warburton D, Stonestreet BS, Oh W. N Engl J Med; 1980 Mar 13; 302(11):598-604. PubMed ID: 7351906 [Abstract] [Full Text] [Related]
51. When to treat the patent ductus arteriosus with indomethacin in very-low-birth-weight infants. Mahony L, Heymann MA, Carnero V, Brett C, Clyman RI. Adv Prostaglandin Thromboxane Leukot Res; 1983 Mar 13; 12():491-4. PubMed ID: 6221636 [No Abstract] [Full Text] [Related]
52. Abdominal pathology requiring laparotomy in very preterm infants is associated with need for surgical closure of patent ductus arteriosus. Röjås S, Borg H, Edenholm M, Sandberg K, Elfvin A. J Pediatr Surg; 2011 Oct 13; 46(10):1898-902. PubMed ID: 22008324 [Abstract] [Full Text] [Related]
53. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Alfaleh K, Smyth JA, Roberts RS, Solimano A, Asztalos EV, Schmidt B, Trial of Indomethacin Prophylaxis in Preterms Investigators. Pediatrics; 2008 Feb 13; 121(2):e233-8. PubMed ID: 18245398 [Abstract] [Full Text] [Related]
55. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study. Ballard HO, Anstead MI, Shook LA. Respir Res; 2007 Jun 05; 8(1):41. PubMed ID: 17550598 [Abstract] [Full Text] [Related]